CD4 dependence of activation threshold and TCR signalling in mouse T lymphocytes.
The effect of CD4 expression on the activation threshold of mouse T lymphocytes has been analysed. To do this, the authors studied the response to antigen and other T cell receptor (TCR) ligands in a series of CD4- mutants obtained from the SR.D10 clone. This non-tumour clone spontaneously arose from the Th2 clone D10.G4.1, and characteristically shows a low threshold for antigen activation as well as reactivity to syngeneic antigen presenting cells (APC). Although SR.D10 CD4- mutant cells can be stimulated by antigen, they need higher antigen concentration or more APC than SR.D10 or CD4 transfectants to yield optimal antigen responses. Furthermore, CD4- clones are not activated by syngeneic APC or by clonotypic antibodies. These effects do not correlate with changes in the expression of cell surface molecules implicated in antigen recognition, like TCR/CD3, CD2, LFA-1, or CD45, or with lower p56lck or p59fyn activity in the mutant cells. Since inhibition experiments using anti-CD4 antibodies have previously shown that activation of the CD4+ T cell clone D10.G4.1 by antigen or alloantigens is largely dependent on CD4, our results indicate that activation by antigen-plus self MHC may become CD4-independent if the activation threshold is lowered enough, e.g. in cells like SR.D10. Expression of CD4 further lowers the activation threshold of the cells, allowing the detection of low-affinity TCR reactivities like those directed at self MHC. Moreover, by using anti-TCR/CD3 antibodies, the authors have confirmed the importance of CD4-associated tyrosine kinase activity in early TCR/CD3 signalling in this Th2 cell line, as (1) upon TCR/CD3 ligation, tyrosine phosphorylation is detected only in those CD3 chains co-precipitating with CD4; and (2) CD4 expression is needed for efficient early tyrosine phosphorylation and detectable p56lck-TCR co-precipitation.
Feito
M J
MJ
Centro de Investigaciones Biológicas, CSIC, Madrid, Spain.
Ballester
S
S
Díez-Orejas
R
R
Ojeda
G
G
Criado
G
G
Portolés
P
P
Rojo
J M
JM
D000818:Animals; D000906:Antibodies / Q000276:immunology; D019138:Antibodies, Blocking / Q000276:immunology; D000911:Antibodies, Monoclonal; D017951:Antigen Presentation; D015152:Blotting, Northern; D018801:CD2 Antigens / Q000276:immunology; D017252:CD3 Complex / Q000276:immunology; D015704:CD4 Antigens / Q000235:genetics* / Q000276:immunology*; D002478:Cells, Cultured; D002999:Clone Cells / Q000276:immunology; D003001:Cloning, Molecular; D005434:Flow Cytometry; D005786:Gene Expression Regulation; D015151:Immunoblotting; D007375:Interleukin-1 / Q000235:genetics; D017493:Leukocyte Common Antigens / Q000276:immunology; D008213:Lymphocyte Activation; D016169:Lymphocyte Function-Associated Antigen-1 / Q000276:immunology; D008285:Major Histocompatibility Complex / Q000276:immunology; D051379:Mice; D010957:Plasmids; D011233:Precipitin Tests; D011494:Protein Kinases / Q000378:metabolism; D011948:Receptors, Antigen, T-Cell / Q000235:genetics*; D011994:Recombinant Proteins / Q000276:immunology; D015398:Signal Transduction / Q000235:genetics*; D013601:T-Lymphocytes / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology; D014162:Transfection
D000906:Antibodies; D019138:Antibodies, Blocking; D000911:Antibodies, Monoclonal; D018801:CD2 Antigens; D017252:CD3 Complex; D015704:CD4 Antigens; D007375:Interleukin-1; D016169:Lymphocyte Function-Associated Antigen-1; D011948:Receptors, Antigen, T-Cell; D011994:Recombinant Proteins; D011494:Protein Kinases; D017493:Leukocyte Common Antigens